Jim Chanos Negative Again on Valeant Pharma (VRX) in CNBC Interview

October 25, 2016 12:41 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Jim Chanos is discussing Valeant Pharma (NYSE: VRX) negative again on CNBC. Says uneconomical to shareholders.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hedge Funds, Short Sales, Trader Talk

Related Entities

Jim Chanos

Add Your Comment